NIH-funded research NIH-funded research

Alzheimer's markers in adults with Down syndrome

Official title: Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)

Funded at University of Pittsburgh at Pittsburgh · NIH-10906278 · Data updated 2026-11-12

This project looks for blood, brain imaging, and genetic signs that show when Alzheimer's starts and progresses in adults with Down syndrome.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 30, 2020
Project endAugust 31, 2026
Funding year2025
Award (this year)$17,980,649
NIH project number5U19AG068054-05
Project IDNIH-10906278 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Down syndrome, typically age 21 and older, including those without symptoms and those with mild cognitive changes, are the intended participants.

Less likely to help

People without Down syndrome, children under 21, or individuals with severe health issues preventing clinic visits would not be eligible and likely would not benefit directly.

What this research studies

You'll join a group of adults with Down syndrome who are followed over time with regular memory tests, brain scans, blood draws, and genetic checks. The team uses imaging (like PET and MRI), fluid biomarkers (blood and sometimes cerebrospinal fluid), and genetic analyses to map how amyloid and tau build up before symptoms appear. Researchers compare these patterns to typical late-onset Alzheimer's to find shared and unique features. That information helps design better ways to detect decline early and choose measures for future prevention trials.

Why it matters

Potential benefit: Could enable earlier detection and better tracking of Alzheimer's in people with Down syndrome, helping guide prevention or treatment trials.

How similar studies have gone: Previous studies have detected amyloid and tau changes in Down syndrome similar to late-onset Alzheimer's, supporting this biomarker approach, while ABC-DS expands on size and detail to answer remaining questions.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Handen, Benjamin L — University of Pittsburgh at Pittsburgh
  • Study coordinator: Handen, Benjamin L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.